Menu

Blog

Archive for the ‘neuroscience’ category: Page 309

Sep 8, 2022

New Device Can Detect Alzheimer’s 17 Years in Advance

Posted by in categories: biotech/medical, neuroscience

Before the first clinical symptoms appear, Alzheimer’s.

Alzheimer’s disease is a disease that attacks the brain, causing a decline in mental ability that worsens over time. It is the most common form of dementia and accounts for 60 to 80 percent of dementia cases. There is no current cure for Alzheimer’s disease, but there are medications that can help ease the symptoms.

Sep 8, 2022

‘Jumping’ genes yield new clues to origins of neurodegenerative disease

Posted by in categories: biotech/medical, neuroscience

The findings also point to possible directions for treatment of the disease.

The results are published Sept. 6 in the journal Neuron.

Almost half the human genome is comprised of transposable elements, long and short stretches of DNA called “jumping genes” for their ability to move from one location of the genome to others. Once called “junk” DNA, these transposable sequences have been shown to play crucial regulatory roles in many biological functions. Once they fulfill these myriad roles, molecular regulators usually silence their expression.

Sep 8, 2022

A memory prosthesis could restore memory in people with damaged brains

Posted by in categories: cyborgs, neuroscience

It works by copying what happens in the hippocampus—a seahorse-shaped region deep in the brain that plays a crucial role in memory. The brain structure not only helps us form short-term memories but also appears to direct memories to other regions for long-term storage.

For more than 10 years, Theodore Berger and Dong Song at the University of Southern California and their colleagues have been developing a way to mimic this process. Their idea is to use brain electrodes to understand the electrical patterns of activity that occur when memories are encoded, and then use those same electrodes to fire similar patterns of activity.

Sep 8, 2022

Martin Ciupa — AI Superintelligence, The Singularity & Neuralink

Posted by in categories: Elon Musk, existential risks, neuroscience, Ray Kurzweil, robotics/AI, singularity

https://www.timventura.com — Martin Ciupa discusses the existential risks and unintended consequences of AI superintelligence and the Singularity, along with concerns about AI augmentation through Neuralink. We also explore the philosophical underpinnings of The Singularity and how it fulfills a long-standing human need for transcendence in a technologically advanced society.

Martin Ciupa is a subject matter expert on artificial intelligence. Martin is the CEO of Remoscope Inc, an AI-based Telehealth startup, and an advisor & consultant to Mindmaze, a Unicorn Neurotech company focuses on applying advanced neuroscience to everyday life. Martin has decades of experience in computing and artificial intelligence, PhD studies in AI, and a Master’s Degree in Cybernetics. He joins us today to discuss AI Superintelligence and the Singularity.

Continue reading “Martin Ciupa — AI Superintelligence, The Singularity & Neuralink” »

Sep 8, 2022

David Pearce and Andrés Gómez Emilsson Chat About the Nature of Reality

Posted by in categories: biotech/medical, neuroscience, robotics/AI, transhumanism

Along the way, they discuss the early days of David’s HedWeb, the Abolitionist Project, the Three Supers of Transhumanism (Superhappiness, Superintelligence, and Superlongevity), philosophy and history of science, the nature of intelligence, field theories of consciousness, anesthesia, empathogens, anti-tolerance drugs, and much more.

Some of the key essays discussed:

Continue reading “David Pearce and Andrés Gómez Emilsson Chat About the Nature of Reality” »

Sep 8, 2022

How a single protein could unlock age-related vision loss

Posted by in categories: biotech/medical, life extension, neuroscience

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.

The study, published recently in the Biophysical Journal, describes the flexible structure of a key blood protein involved in macular degeneration and other age-related diseases, such as Alzheimer’s and atherosclerosis.

“Proteins in the blood are under constant and changing pressure because of the different ways blood flows throughout the body,” says Marassi. “For example, blood flows more slowly through small blood vessels in the eyes compared to larger arteries around the heart. Blood proteins need to be able to respond to these changes, and this study gives us fundamental truths about how they adapt to their environment, which is critical to targeting those proteins for future treatments.”

Sep 7, 2022

Researchers Demonstrate Brainwave Synchronization Without Physical Presence

Posted by in categories: biotech/medical, entertainment, neuroscience

Researchers demonstrated that the brains of people playing an online game together were synchronized without physical presence.

Online gaming and other types of online social interaction have become increasingly popular during the COVID pandemic. This trend is likely to continue due to increased remote working and investments in social technology.

Previous research has shown that people’s brains activate in a similar and simultaneous way during social interaction. Such inter-brain neural synchronization has been associated with empathy and cooperation in face-to-face situations. However, its role in online, remote interaction has remained unknown.

Sep 7, 2022

David Chalmers on Reality+: Virtual Worlds and the Problems of Philosophy

Posted by in categories: ethics, neuroscience, virtual reality

David Chalmers, Professor of Philosophy and Neural Science at NYU, joins us to discuss his newest book Reality+: Virtual Worlds and the Problems of Philosophy.

Topics discussed in this episode include:

Continue reading “David Chalmers on Reality+: Virtual Worlds and the Problems of Philosophy” »

Sep 7, 2022

Using graph-powered analytics to keep track of ESG in the real world

Posted by in categories: business, governance, neuroscience, sustainability

Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.

Editorial Disclosure: The author of this article has a business relationship with James Phare, CEO and founder of Neural Alpha.

What does sustainability actually mean for organizations? Can it be measured, and if yes, how so? Often, these are obvious questions with less-than-obvious answers, even for sustainability and environmental, social and governance (ESG) professionals like James Phare.

Sep 6, 2022

Deadly brain tumors destroyed in mice with revolutionary new therapy

Posted by in categories: biotech/medical, neuroscience

Glioblastoma is one of the most aggressive types of brain cancer known to man. For many, the chance of survival is often low. However, a new type of brain tumor therapy could help change things for the better. The therapy, which relies on destroying the “power source” of the cancer, has shown considerable success in mice. The scientists are hopeful it will work the same in humans.

The new therapy hopes to destroy the “power source” of glioblastoma tumors. A new study led by Israeli scientists shows that glioblastoma relies on specific brain cells to fuel the growth of its tumors. As a result, scientists began to look at ways to treat cancer by removing those cells instead. The new brain tumor therapy could completely starve out the cancer cells, allowing patients to enter remission.

Normally doctors would use chemotherapy to target the tumors directly. However, by removing brain cells called Astrocytes, scientists found they could starve out glioblastoma tumors in mice. Further, the tumors remained gone for as long as the astrocytes were repressed. And, even when they stopped suppressing, Dr. Lior Mayo, lead author on the study, says that 85 percent of mice stayed in remission.